tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Edwards Lifesciences raises FY26 adjusted EPS view to $2.90-$3.05
PremiumThe FlyEdwards Lifesciences raises FY26 adjusted EPS view to $2.90-$3.05
4d ago
Edwards Lifesciences upgraded to Buy from Hold at TD Cowen
Premium
The Fly
Edwards Lifesciences upgraded to Buy from Hold at TD Cowen
5d ago
Edwards Lifesciences price target raised to $108 from $104 at Goldman Sachs
Premium
The Fly
Edwards Lifesciences price target raised to $108 from $104 at Goldman Sachs
5d ago
Edwards Lifesciences Advances Smart Surgery Monitoring With Completed SMART TRENDS Study
PremiumCompany AnnouncementsEdwards Lifesciences Advances Smart Surgery Monitoring With Completed SMART TRENDS Study
22d ago
Edwards Lifesciences upgraded to Overweight from Neutral at JPMorgan
Premium
The Fly
Edwards Lifesciences upgraded to Overweight from Neutral at JPMorgan
27d ago
Edwards Lifesciences: Buy Rating on Structural Heart Leadership, Accelerating TAVR/TMTT Growth, and Durable Double‑Digit Upside
Premium
Ratings
Edwards Lifesciences: Buy Rating on Structural Heart Leadership, Accelerating TAVR/TMTT Growth, and Durable Double‑Digit Upside
27d ago
Edwards Lifesciences price target lowered to $87 from $88 at Baird
PremiumThe FlyEdwards Lifesciences price target lowered to $87 from $88 at Baird
29d ago
Edwards Lifesciences Completes Key Study on SAPIEN XT THV
Premium
Company Announcements
Edwards Lifesciences Completes Key Study on SAPIEN XT THV
29d ago
Edwards Lifesciences price target raised to $101 from $96 at Citi
Premium
The Fly
Edwards Lifesciences price target raised to $101 from $96 at Citi
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100